Friday, July 10, 2026

pharma · Multiple Myeloma · Ovarian Cancer

pharma&

pharmaand is a pharma organization headquartered in Wien, AT. Primary therapeutic focus areas include Multiple Myeloma, Ovarian Cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s

Vienna, AT HQ
2017 Founded
210 Employees
EMA registrant Type
Company details
Clinical program

Panobinostat Capsules

Phase 2 · small molecule · Multiple Myeloma

Panobinostat Capsules for Multiple Myeloma is a Phase 2 program (small_molecule) at pharmaand GmbH with 1 ClinicalTrials.gov record(s).

← All pharmaand GmbH projects Phase 2 small molecule completed

Internal code CLBH589D2222

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
pharmaand GmbH
Phase
Phase 2
Modality
small_molecule
Indication
Multiple Myeloma
Status
completed
Trials
1